News + Filings
Key Docs

Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Eliem Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
In millions, except per share itemsDec-31-20Dec-31-19
Revenues  8.82.5
            Revenue growth  248.4% 
Cost of goods sold  8.82.5
Gross profit  0.00.0
            Gross margin  0.0%0.0%
Selling, general and administrative   [+]2.40.7
Other operating expenses  9.34.0
EBIT   [+]-11.8-4.7
            EBIT margin  -134.2%-186.6%
Non-recurring items   [+]9.22.8
Other income (expense), net   [+]-2.00.1
Pre-tax income  -23.0-7.4
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -23.0-7.4
            Net margin  -261.8%-293.6%
Basic EPS   [+]($5.25)($2.22)
Diluted EPS   [+]($5.25)($2.22)
Shares outstanding (basic)   [+]4.43.3
Shares outstanding (diluted)   [+]4.43.3
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy